![51I9WLrfwsL._CLa|687,500|51MZQLzF4KL.jpg,51hr5jJXS6L.jpg|0,0,312,500+375,0,312,500+156,0,375,500_._SY200_.jpg 51I9WLrfwsL._CLa|687,500|51MZQLzF4KL.jpg,51hr5jJXS6L.jpg|0,0,312,500+375,0,312,500+156,0,375,500_._SY200_.jpg](https://m.media-amazon.com/images/I/51I9WLrfwsL._CLa%7C687,500%7C51MZQLzF4KL.jpg,51hr5jJXS6L.jpg%7C0,0,312,500+375,0,312,500+156,0,375,500_._SY200_.jpg)
51I9WLrfwsL._CLa|687,500|51MZQLzF4KL.jpg,51hr5jJXS6L.jpg|0,0,312,500+375,0,312,500+156,0,375,500_._SY200_.jpg
![Psychotherapy for cancer patients: A systematic review and meta-analysis - Ng Chong Guan, Salina Mohamed, Lai Kian Tiah, Teoh Kar Mun, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, 2016 Psychotherapy for cancer patients: A systematic review and meta-analysis - Ng Chong Guan, Salina Mohamed, Lai Kian Tiah, Teoh Kar Mun, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, 2016](https://journals.sagepub.com/cms/10.1177/0091217416680197/asset/images/large/10.1177_0091217416680197-fig2.jpeg)
Psychotherapy for cancer patients: A systematic review and meta-analysis - Ng Chong Guan, Salina Mohamed, Lai Kian Tiah, Teoh Kar Mun, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, 2016
![Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis | Nature Communications Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-017-01236-6/MediaObjects/41467_2017_1236_Fig1_HTML.jpg)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis | Nature Communications
![Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/07c0f8e9-e060-411b-ab32-2428c5a93696/gr1_lrg.jpg)
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet
![Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer | Journal of Medicinal Chemistry Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm060319f/asset/images/large/jm060319fn00001.jpeg)